Clinical Trial Update: Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Sorafenib in patients with previously treated advanced hepatocellular carcinoma assessed its efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: Bo Hyun Kim | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED